Target intelligence / Profile preview

Snake venom disintegrin

Molecular classification
Snake venom toxin, Integrin ligand, Protein
01

Overview

Disintegrins and disintegrin-like proteins are a family of small, cysteine-rich polypeptides found in the venoms of vipers and rattlesnakes, including Bothrops asper and Crotalus durissus (UniProt, Family: Disintegrin). These molecules function as potent antagonists of integrin receptors, particularly the platelet receptor αIIbβ3 and various αv integrins on endothelial cells (McLane et al., 2004, Frontiers in Bioscience). By mimicking the Arg-Gly-Asp (RGD) recognition sequence, they competitively inhibit the binding of adhesive glycoproteins like fibrinogen, leading to the suppression of platelet aggregation and cell-matrix interactions (Calvete et al., 2005, Venom Genomics and Proteomics). This activity is a primary driver of the hemorrhagic effects observed during snakebite envenomation, as it disrupts normal blood clotting and vascular stability (WHO Guidelines for Snake Antivenoms). While they are pathological in the context of a snakebite, their high specificity for integrins has made them invaluable templates for the development of clinical antiplatelet drugs such as eptifibatide and tirofiban. In clinical toxicology, these toxins are the specific targets for neutralization by polyvalent antivenoms, which contain antibodies that bind the toxins and prevent their interaction with host receptors. Research also explores their potential as anti-angiogenic and anti-metastatic agents in cancer therapy due to their ability to block integrin-mediated cell signaling. Despite their therapeutic utility as lead compounds, the native toxins pose significant safety risks, including severe systemic bleeding and potential immunogenicity if used directly as therapeutics.

Other names
DisintegrinDisintegrin-like proteinSnake venom metalloproteinase disintegrin-like domainRGD-containing snake venom toxinBasperadCrotatroxin
02

Mechanism of action

Neutralization of toxin activity through antibody-mediated sequestration, which prevents the toxin from interacting with host integrin receptors such as αIIbβ3 and αvβ3 (WHO Guidelines for Snake Antivenoms).

03

Biological functions

Inhibition of platelet aggregationCell adhesion inhibitionAngiogenesis inhibitionAnticoagulation
04

Disease associations

Snakebite envenomationThrombosisCancerCardiovascular disease
05

Safety considerations

HemorrhageAnaphylaxis (associated with antivenom treatment)Serum sicknessThrombocytopenia
06

Interacting drugs

Bothrops polyvalent antivenom

1 more in the full profile.

07

Biomarkers

Platelet aggregation inhibitionBleeding timeFibrinogen levelsProthrombin time

Beyond the preview

Go deeper on Snake venom disintegrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Snake venom disintegrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call